Exploring the scientific showdown between two-drug and three-drug HIV treatment regimens, examining efficacy, safety, and long-term benefits.
Discover how dolutegravir and boosted darunavir dual therapy is revolutionizing HIV treatment for highly treatment-experienced individuals with sustained viral suppression.